Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use during the high-risk college transition period. Digital tools like this are being studied because they can reach large numbers of students at low cost. Results from this trial provide direct evidence on whether app-based support can produce measurable improvements in student mental health and substance use outcomes.
#4 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides empirical evidence for the clinical efficacy of a student-centered digital intervention during a high-risk developmental period when mental health and substance use disorders commonly emerge. The findings establish whether scalable mobile health platforms can effectively reduce the burden of untreated psychiatric and addiction disorders in university populations, where traditional in-person mental health services often face capacity constraints. Given the widespread accessibility of mobile technology among young adults, demonstration of Minder’s effectiveness could inform clinical implementation strategies for extending mental health and substance use treatment reach to underserved student populations.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 This randomized controlled trial evaluates a student-codeveloped mobile app for mental health and substance use support during the vulnerable university transition period, addressing a genuine gap in scalable digital interventions for this population. While the study design is rigorous and the app’s participatory development is commendable, important confounders merit consideration: selection bias toward digitally-engaged students, heterogeneity in baseline symptom severity, variability in app engagement patterns, and the challenge of isolating the app’s effect from concurrent supportive campus resources or natural remission rates. The abstract provided does not specify primary outcomes, effect sizes, or dropout rates, making it difficult to assess clinical meaningfulness versus statistical significance. For practitioners advising students on mental health tools, this work suggests mobile apps can be viable adjuncts to traditional care, but clinicians should still conduct individualized risk assessment, clarify whether the student is receiving concurrent professional support, and monitor for false reassurance that an app alone addresses moderate to severe mental health or substance use concerns. Encouraging
| |